CVE-2024-2275

published 8 Mar 2024 · updated 1 Aug 2024

Bdtask G-Prescription Gynaecology & OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting

3.4LowCVSS 2.4EPSS 0%1 public exploits

A public exploit exists; no exploitation in the wild has been reported. EPSS puts the chance of exploitation in the next 30 days at 0%. No fixed version is recorded.

A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Affected

Vendors, products and packages with version ranges

VendorProductVersionsFixed
Bdtask=1.0

Exploit evidence

1 public sources

Timeline

Every event on this vulnerability

Embed

A live severity badge for an advisory, README or ticket

CVE-2024-2275 severity on Zeptric[![CVE-2024-2275](https://zeptric.io/badge/cve/CVE-2024-2275.svg)](https://zeptric.io/cve/CVE-2024-2275)